Biofrontera Stock (NASDAQ:BFRI)
Previous Close
$1.09
52W Range
$0.56 - $1.21
50D Avg
$0.98
200D Avg
$0.93
Market Cap
$13.44M
Avg Vol (3M)
$271.50K
Beta
0.82
Div Yield
-
BFRI Company Profile
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
BFRI Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
Annual
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Government and Payor Rebates | $310.00K | $264.00K | $157.00K |
| Co-pay Assistance Program | $165.00K | $675.00K | - |
| Returns | $52.00K | $53.00K | $180.00K |
| Prompt Pay Discounts | $6.00K | $67.00K | $7.00K |
| CoPay Assistance Program | - | - | $374.00K |
Latest
Fiscal year ends in Dec 25 | Currency in USD